health pharma news today obesity drugs glp-1 Once people understood glucagonlike peptide 1 (GLP-1) drugs' potential for weight loss, the race among pharmaceutical companies was on. Among the current options, Wegovy can help people lose an average of 10 GLP-1 drugs transform obesity care,

Ro Ro is a strong telehealth platform that offers personalized medical care across different medical conditions, such as weight loss, fertility, and sexual health

Legal documents indicate the weekly injectable may cause long-term health conditions, including gastroparesis, bowel blockage, and vision disturbances

Several indirect mechanisms may contribute to fatigue in patients taking GLP-1 receptor agonists

The review will adhere to the methodology outlined in the Joanna Briggs Institute Reviewers Manual [2], and will be reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) [8]